Page last updated: 2024-12-05

ethyl isothiocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethyl isothiocyanate : An isothiocyanate having an ethyl group attached to the nitrogen. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10966
CHEMBL ID2251727
CHEBI ID85098
MeSH IDM0117398

Synonyms (36)

Synonym
ccris 7323
ai3-18428
nsc 84212
einecs 208-831-2
542-85-8
nsc84212
isothiocyanic acid, ethyl ester
ethyl isothiocyanate
nsc-84212
ethane, isothiocyanato-
isothiocyanatoethane
ethyl isothiocyanate, 97%
isothiocyanic acid ethyl ester
I0188
AKOS000119775
3284mj2t8p ,
unii-3284mj2t8p
FT-0627522
chebi:85098 ,
fema no. 4420
CHEMBL2251727
ethyl isothiocyanate [mi]
ethyl isothiocyanate [fhfi]
ethylisothiocyanate
DTXSID2060258
ethylisothio-cyanate
isothiocyanato-ethane
1-isothiocyanatoethane #
mfcd00004820
J-521605
F0001-1427
BCP05940
Q27158332
STL194264
D94745
EN300-19657
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
isothiocyanateAn organosulfur compound with the general formula R-N=C=S.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID1105169Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 393 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105171Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 79 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105111Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 79 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105203Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2358 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105151Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 550 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105109Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 786 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105204Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 1572 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105206Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 708 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105240Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 39 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105238Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 393 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105172Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 39 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105205Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 786 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105236Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 786 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105239Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 79 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105092In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 79 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105237Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 550 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105127Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105141Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2358 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105168Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 786 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105134Fungistatic activity in Sclerotinia sclerotiorum assessed as viability in volatile phase at 786 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105110Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 393 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105207Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 550 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105170Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 236 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105125Fungistatic activity in Sclerotinia sclerotiorum assessed as sclerotial viability measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105091In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 158 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105126Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105112Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 39 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's4 (44.44)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.59 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index44.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (11.11%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]